Advertisement

Psychopharmacology

, Volume 207, Issue 3, pp 511–512 | Cite as

Amnestic effects of sodium oxybate are less than those of triazolam—reply to Drs. Zvosec and Smith

  • Lawrence P. Carter
  • Miriam Z. Mintzer
  • Roland R. Griffiths
Reply
  • 28 Downloads

We would like to thank Drs. Zvosec and Smith for their compliments regarding our recent study of the effects of sodium oxybate and triazolam on different types of memory processes. We agree that these topics are important, in need of rigorous study, and have practical clinical implications.

We also agree with Drs. Zvosec and Smith that there are potential differences between the number of forensic cases in which a drug can be detected and in which a drug was actually ingested. The difference between these two numbers is likely to be dependent on several factors, such as the dose of drug administered, the rate of drug metabolism, the storage of drug in body tissues, the ease of drug detection, and the availability of specific and sensitive forensic tests for the drug. For these reasons, the difference between the number of cases in which a drug is detected and the number of cases in which a drug is administered is likely to be larger for GHB compared to other drugs. However, even...

Keywords

Triazolam Adverse Event Reporting Sodium Oxybate Anterograde Amnesia Amnestic Effect 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Barker JC, Karsoho H (2008) Hazardous use of gamma hydroxybutyrate: driving under the influence. Subst Use Misuse 43:1507–1520CrossRefPubMedGoogle Scholar
  2. Carter LP, Griffiths RR, Mintzer MZ (2009) Cognitive, psychomotor, and subjective effects of sodium oxybate and triazolam in healthy volunteers. Psychopharmacology (Berl) 206:141–154CrossRefGoogle Scholar
  3. Carter LP, Richards BD, Mintzer MZ, Griffiths RR (2006) Relative abuse liability of GHB in humans: a comparison of psychomotor, subjective, and cognitive effects of supratherapeutic doses of triazolam, pentobarbital, and GHB. Neuropsychopharmacology 31:2537–2551CrossRefPubMedGoogle Scholar
  4. ElSohly MA, Salamone SJ (1999) Prevalence of drugs used in cases of alleged sexual assault. J Anal Toxicol 23:141–146PubMedGoogle Scholar
  5. Miotto KA, Darakjian J, Basch J, Murray S, Zogg J, Rawson R (2001) Gammahydroxybutyric acid: patterns of use, effects, and withdrawal. Am J Addict 10:232–241CrossRefPubMedGoogle Scholar
  6. Oxford Centre for Evidence-based Medicine (2009) Levels of Evidence. <http://www.cebm.net/index.aspx?o=1025>. Accessed 24 Aug 2009
  7. Pan YM, Gill GN, Tilson CS, Wall WH, McCurdy HH (2001) Improved procedure for the analysis of gamma-hydroxybutyrate and ethylene glycol in whole blood. J Anal Toxicol 25:328–332PubMedGoogle Scholar
  8. Slaughter L (2000) Involvement of drugs in sexual assault. J Reprod Med 45:425–430PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Lawrence P. Carter
    • 2
  • Miriam Z. Mintzer
    • 1
  • Roland R. Griffiths
    • 3
  1. 1.Department of Psychiatry and Behavioral SciencesJohns Hopkins University School of MedicineBaltimoreUSA
  2. 2.Department of Psychiatry, Center for Addiction ResearchUniversity of Arkansas for Medical SciencesLittle RockUSA
  3. 3.Department of Psychiatry and Behavioral Sciences, Department of NeuroscienceJohns Hopkins University School of MedicineBaltimoreUSA

Personalised recommendations